Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy

Bibliographic Details
Main Author: Silva Junior, João Manoel da
Publication Date: 2012
Other Authors: Rezende, Ederlon, Amendola, Cristina Prada, Tomita, Rafael, Torres, Daniele, Ferrari, Maria Tereza, Toledo, Diogo Oliveira, Oliveira, Amanda Maria Ribas Rosa, Marques, Juliana Andreia
Format: Article
Language: eng
Source: São Paulo medical journal (Online)
Download full: https://periodicosapm.emnuvens.com.br/spmj/article/view/1410
Summary: CONTEXT AND OBJECTIVE: Anemia and blood transfusions are common in intensive care. This study aimed to evaluate epidemiology and outcomes among critically ill patients under a restrictive transfusion strategy. DESIGN AND SETTING: Prospective observational cohort study in an intensive care unit (ICU) at a tertiary hospital. METHODS: All adults admitted to the ICU over a one-year period who remained there for more than 72 hours were included, except those with acute coronary syndrome, ischemic stroke, acute hemorrhage, prior transfusion, pregnant women and Jehovah’s Witnesses. The restrictive strategy consisted of transfusion indicated when hemoglobin levels were less than or equal to 7.0 g/dl. RESULTS: The study enrolled 167 patients; the acute physiology and chronic health evaluation II (APACHE II) score was 28.9 ± 6.5. The baseline hemoglobin level was 10.6 ± 2.2 g/dl and on day 28, it was 8.2 ± 1.3 g/dl (P < 0.001). Transfusions were administered to 35% of the patients. In the transfusion group, 61.1% did not survive, versus 48.6% in the non-transfusion group (P = 0.03). Transfusion was an independent risk factor for mortality (P = 0.011; odds ratio, OR = 2.67; 95% confidence interval, CI = 1.25 to 5.69). ICU stay and hospital stay were longer in the transfusion group: 20.0 (3.0-83.0) versus 8.0 (3.0-63.0) days (P < 0,001); and 24.0 (3.0-140.0) versus 14.0 (3.0-80.0) days (P = 0.002), respectively. CONCLUSIONS: In critically ill patients, there was a reduction in hemoglobin with increasing length of ICU stay. Moreover, transfusion was associated with worse prognoses.
id APM-1_edc83404ff1586e4b2b9df16f7b29d58
oai_identifier_str oai:ojs.diagnosticoetratamento.emnuvens.com.br:article/1410
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategyTransfusões de concentrados de hemácias pioram os resultados mesmo em pacientes graves, submetidos a estratégia restritiva de transfusãoAnemiaTransfusão de sangueCuidados intensivosMortalidade hospitalarMorbidadeAnemiaBlood transfusionIntensive careHospital mortalityMorbidityCONTEXT AND OBJECTIVE: Anemia and blood transfusions are common in intensive care. This study aimed to evaluate epidemiology and outcomes among critically ill patients under a restrictive transfusion strategy. DESIGN AND SETTING: Prospective observational cohort study in an intensive care unit (ICU) at a tertiary hospital. METHODS: All adults admitted to the ICU over a one-year period who remained there for more than 72 hours were included, except those with acute coronary syndrome, ischemic stroke, acute hemorrhage, prior transfusion, pregnant women and Jehovah’s Witnesses. The restrictive strategy consisted of transfusion indicated when hemoglobin levels were less than or equal to 7.0 g/dl. RESULTS: The study enrolled 167 patients; the acute physiology and chronic health evaluation II (APACHE II) score was 28.9 ± 6.5. The baseline hemoglobin level was 10.6 ± 2.2 g/dl and on day 28, it was 8.2 ± 1.3 g/dl (P < 0.001). Transfusions were administered to 35% of the patients. In the transfusion group, 61.1% did not survive, versus 48.6% in the non-transfusion group (P = 0.03). Transfusion was an independent risk factor for mortality (P = 0.011; odds ratio, OR = 2.67; 95% confidence interval, CI = 1.25 to 5.69). ICU stay and hospital stay were longer in the transfusion group: 20.0 (3.0-83.0) versus 8.0 (3.0-63.0) days (P < 0,001); and 24.0 (3.0-140.0) versus 14.0 (3.0-80.0) days (P = 0.002), respectively. CONCLUSIONS: In critically ill patients, there was a reduction in hemoglobin with increasing length of ICU stay. Moreover, transfusion was associated with worse prognoses.CONTEXTO E OBJETIVO: Anemia e transfusões sanguíneas são comuns em terapia intensiva. O objetivo deste estudo foi investigar a epidemiologia e resultados em pacientes críticos sob o regime de transfusão restritiva. TIPO DE ESTUDO E LOCAL: Estudo de coorte, prospectivo e observacional em unidade de terapia intensiva de um hospital terciário. MÉTODOS: Foram incluídos todos adultos admitidos na unidade durante um ano e que permaneceram internados por mais de 72 horas, exceto pacientes com lesão coronariana aguda, isquemia cerebral aguda, hemorragia aguda, transfusão anterior, mulheres grávidas e testemunhas de Jeová. A estratégia restritiva consiste na transfusão indicada com a hemoglobina inferior ou igual a 7.0 g/dl. RESULTADOS: Totalizando 167 pacientes incluídos, APACHE II (Acute Physiology and Chronic Health disease II) foi de 28,9 ± 6,5. O valor da hemoglobina basal foi de 10,6 ± 2.2 g/dl e no 28o dia foi de 8,2 ± 1.3 g/dl (P < 0,001). 35% dos pacientes receberam transfusões. No grupo de transfusão 61,1% não sobreviveram versus 48,6% do grupo não transfusão (P = 0,03). A transfusão foi fator de risco independente de mortalidade (P = 0,011; odds ratio, OR = 2,67; intervalo de confiança, IC 95% = 1,25-5,69). A internação na unidade de terapia intensiva e hospitalar foi maior no grupo de transfusão: 20,0 (3,0-83,0) versus 8,0 (3,0-63,0) dias (P < 0,001); e 24,0 (3,0-140,0) versus 14,0 (3,0-80,0) dias (P = 0,002). CONCLUSÕES: Em pacientes graves, observou-se redução da hemoglobina com a progressão da permanência na UTI. Além disso, a transfusão foi associada com piores prognósticos.São Paulo Medical JournalSão Paulo Medical Journal2012-03-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicosapm.emnuvens.com.br/spmj/article/view/1410São Paulo Medical Journal; Vol. 130 No. 2 (2012); 77-83São Paulo Medical Journal; v. 130 n. 2 (2012); 77-831806-9460reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APMenghttps://periodicosapm.emnuvens.com.br/spmj/article/view/1410/1322https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva Junior, João Manoel daRezende, EderlonAmendola, Cristina PradaTomita, RafaelTorres, DanieleFerrari, Maria TerezaToledo, Diogo OliveiraOliveira, Amanda Maria Ribas RosaMarques, Juliana Andreia2023-09-03T21:14:18Zoai:ojs.diagnosticoetratamento.emnuvens.com.br:article/1410Revistahttp://www.scielo.br/spmjPUBhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2023-09-03T21:14:18São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
Transfusões de concentrados de hemácias pioram os resultados mesmo em pacientes graves, submetidos a estratégia restritiva de transfusão
title Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
spellingShingle Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
Silva Junior, João Manoel da
Anemia
Transfusão de sangue
Cuidados intensivos
Mortalidade hospitalar
Morbidade
Anemia
Blood transfusion
Intensive care
Hospital mortality
Morbidity
title_short Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
title_full Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
title_fullStr Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
title_full_unstemmed Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
title_sort Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy
author Silva Junior, João Manoel da
author_facet Silva Junior, João Manoel da
Rezende, Ederlon
Amendola, Cristina Prada
Tomita, Rafael
Torres, Daniele
Ferrari, Maria Tereza
Toledo, Diogo Oliveira
Oliveira, Amanda Maria Ribas Rosa
Marques, Juliana Andreia
author_role author
author2 Rezende, Ederlon
Amendola, Cristina Prada
Tomita, Rafael
Torres, Daniele
Ferrari, Maria Tereza
Toledo, Diogo Oliveira
Oliveira, Amanda Maria Ribas Rosa
Marques, Juliana Andreia
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva Junior, João Manoel da
Rezende, Ederlon
Amendola, Cristina Prada
Tomita, Rafael
Torres, Daniele
Ferrari, Maria Tereza
Toledo, Diogo Oliveira
Oliveira, Amanda Maria Ribas Rosa
Marques, Juliana Andreia
dc.subject.por.fl_str_mv Anemia
Transfusão de sangue
Cuidados intensivos
Mortalidade hospitalar
Morbidade
Anemia
Blood transfusion
Intensive care
Hospital mortality
Morbidity
topic Anemia
Transfusão de sangue
Cuidados intensivos
Mortalidade hospitalar
Morbidade
Anemia
Blood transfusion
Intensive care
Hospital mortality
Morbidity
description CONTEXT AND OBJECTIVE: Anemia and blood transfusions are common in intensive care. This study aimed to evaluate epidemiology and outcomes among critically ill patients under a restrictive transfusion strategy. DESIGN AND SETTING: Prospective observational cohort study in an intensive care unit (ICU) at a tertiary hospital. METHODS: All adults admitted to the ICU over a one-year period who remained there for more than 72 hours were included, except those with acute coronary syndrome, ischemic stroke, acute hemorrhage, prior transfusion, pregnant women and Jehovah’s Witnesses. The restrictive strategy consisted of transfusion indicated when hemoglobin levels were less than or equal to 7.0 g/dl. RESULTS: The study enrolled 167 patients; the acute physiology and chronic health evaluation II (APACHE II) score was 28.9 ± 6.5. The baseline hemoglobin level was 10.6 ± 2.2 g/dl and on day 28, it was 8.2 ± 1.3 g/dl (P < 0.001). Transfusions were administered to 35% of the patients. In the transfusion group, 61.1% did not survive, versus 48.6% in the non-transfusion group (P = 0.03). Transfusion was an independent risk factor for mortality (P = 0.011; odds ratio, OR = 2.67; 95% confidence interval, CI = 1.25 to 5.69). ICU stay and hospital stay were longer in the transfusion group: 20.0 (3.0-83.0) versus 8.0 (3.0-63.0) days (P < 0,001); and 24.0 (3.0-140.0) versus 14.0 (3.0-80.0) days (P = 0.002), respectively. CONCLUSIONS: In critically ill patients, there was a reduction in hemoglobin with increasing length of ICU stay. Moreover, transfusion was associated with worse prognoses.
publishDate 2012
dc.date.none.fl_str_mv 2012-03-03
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicosapm.emnuvens.com.br/spmj/article/view/1410
url https://periodicosapm.emnuvens.com.br/spmj/article/view/1410
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://periodicosapm.emnuvens.com.br/spmj/article/view/1410/1322
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv São Paulo Medical Journal
São Paulo Medical Journal
publisher.none.fl_str_mv São Paulo Medical Journal
São Paulo Medical Journal
dc.source.none.fl_str_mv São Paulo Medical Journal; Vol. 130 No. 2 (2012); 77-83
São Paulo Medical Journal; v. 130 n. 2 (2012); 77-83
1806-9460
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1825135063909531648